HLA II类(DR、DQ、DP)基因分别与两项糖尿病预防试验中从血清转换到1型糖尿病发病的进展相关
研究对糖尿病预防试验-1和口服胰岛素随机糖尿病预防试验中1216名参与者行HLAII基因靶向测序,用Cox回归评估与疾病进展的关联。发现DQA1-DQB1、DPA1-DPB1、DRB1-DRB3及DRB1单等位基因与进展存在关联,提示HLAII多态性影响从胰岛自身免疫到1型糖尿病的进展。
要点
- DQA1*03:01-DQB1*03:02与进展风险升高相关(HR=1.25,P=3.50*10-3)。
- 调整DQ后,DPA1*02:01-DPB1*11:01与进展风险升高相关(HR=1.98,P=0.021)。
- 共享DRB1*03:01的DRB3单倍型与进展呈相反关联,提示DRB3作用。
核心结论
- 结果提示HLAII多态性影响具有胰岛自身抗体的高危受试者从胰岛自身免疫到1型糖尿病的进展。
研究设计与样本
- 采用下一代靶向测序对来自糖尿病预防试验-1和口服胰岛素随机糖尿病预防试验的1216名参与者行8个HLAII基因(DQA1、DQB1、DRB1、DRB3、DRB4、DRB5、DPA1、DPB1)基因分型。
- 通过连锁不平衡构建DQ、DP和DR单倍型,并结合可用临床协变量应用Cox回归模型评估HLAII免疫原性关联与疾病进展。
主要发现
- 本次研究更新了既往报道的DQA1*03:01-DQB1*03:02(HR=1.25,P=3.50*10-3)和DQA1*03:03-DQB1*03:01(HR=0.56,P=1.16*10-3)遗传关联,并新发现DQA1*05:01-DQB1*02:01的风险关联(HR=1.19,P=0.041)。
- 调整DQ后,DPA1*02:01-DPB1*11:01和DPA1*01:03-DPB1*03:01与进展呈相反关联(HR分别为1.98和0.70,P分别为0.021和6.16*10-3)。
- 共享DRB1*03:01的DRB1*03:01-DRB3*01:01和DRB1*03:01-DRB3*02:02呈相反关联(HR分别为0.73和1.44,P分别为0.04和0.019),提示DRB3的作用。
- DRB1*12:01-DRB3*02:02和DRB1*01:03单独与进展相关(HR分别为2.6和2.32,P分别为0.018和0.039)。
- 通过枚举所有异二聚体,发现DQ和DP均可与疾病进展存在关联。
关键数值与推荐
- DQA1*03:01-DQB1*03:02的HR=1.25(P=3.50*10-3)。
- DQA1*03:03-DQB1*03:01的HR=0.56(P=1.16*10-3)。
- DQA1*05:01-DQB1*02:01的HR=1.19(P=0.041)。
- DPA1*02:01-DPB1*11:01的HR=1.98(P=0.021),DPA1*01:03-DPB1*03:01的HR=0.70(P=6.16*10-3)。
- DRB1*03:01-DRB3*01:01的HR=0.73(P=0.04),DRB1*03:01-DRB3*02:02的HR=1.44(P=0.019);DRB1*12:01-DRB3*02:02的HR=2.6(P=0.018),DRB1*01:03的HR=2.32(P=0.039)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore associations of HLA class II genes (HLAII) with the progression of islet autoimmunity from asymptomatic to symptomatic type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: Next-generation targeted sequencing was used to genotype eight HLAII genes (DQA1, DQB1, DRB1, DRB3, DRB4, DRB5, DPA1, DPB1) in 1,216 participants from the Diabetes Prevention Trial-1 and Randomized Diabetes Prevention Trial with Oral Insulin sponsored by TrialNet. By the linkage disequilibrium, DQA1 and DQB1 are haplotyped to form DQ haplotypes; DP and DR haplotypes are similarly constructed. Together with available clinical covariables, we applied the Cox regression model to assess HLAII immunogenic associations with the disease progression. RESULTS: First, the current investigation updated the previously reported genetic associations of DQA1*03:01-DQB1*03:02 (hazard ratio [HR] = 1.25, P = 3.50*10-3) and DQA1*03:03-DQB1*03:01 (HR = 0.56, P = 1.16*10-3), and also uncovered a risk association with DQA1*05:01-DQB1*02:01 (HR = 1.19, P = 0.041). Second, after adjusting for DQ, DPA1*02:01-DPB1*11:01 and DPA1*01:03-DPB1*03:01 were found to have opposite associations with progression (HR = 1.98 and 0.70, P = 0.021 and 6.16*10-3, respectively). Third, DRB1*03:01-DRB3*01:01 and DRB1*03:01-DRB3*02:02, sharing the DRB1*03:01, had opposite associations (HR = 0.73 and 1.44, P = 0.04 and 0.019, respectively), indicating a role of DRB3. Meanwhile, DRB1*12:01-DRB3*02:02 and DRB1*01:03 alone were found to associate with progression (HR = 2.6 and 2.32, P = 0.018 and 0.039, respectively). Fourth, through enumerating all heterodimers, it was found that both DQ and DP could exhibit associations with disease progression. CONCLUSIONS: These results suggest that HLAII polymorphisms influence progression from islet autoimmunity to T1D among at-risk subjects with islet autoantibodies.
引用
- Zhao LP, Papadopoulos GK, Skyler JS, et al. HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07). Diabetes Care. 2024. PMID: 38498185. doi:10.2337/dc23-1947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。